Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (112)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Andersen, P. M.
Right arrow Articles by Marklund, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersen, P. M.
Right arrow Articles by Marklund, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 120, Issue 10 1723-1737, Copyright © 1997 by Oxford University Press

REVIEWS

Phenotypic heterogeneity in motor neuron disease patients with CuZn- superoxide dismutase mutations in Scandinavia

PM Andersen, P Nilsson, ML Keranen, L Forsgren, J Hagglund, M Karlsborg, LO Ronnevi, O Gredal and SL Marklund
Department of Neurology, Umea University Hospital, Sweden.

Four-hundred and fifty-one blood samples from Scandinavian patients with motor neuron disease were analysed for mutations in the CuZn- superoxide dismutase gene. Forty-one (9.6%) of the 427 patients with the amyotrophic lateral sclerosis (ALS) form of the disease were found to have a disease-associated mutation, and 14 of these patients were apparently sporadic cases. A mutation was found in 12 of the 51 families with recognized familial ALS. The five different mutations found (Ala4Val, Val14Gly, Asp76Tyr, Asp90Ala, Gly127insTGGG) have different genetic characteristics and are associated with very variable phenotypes spanning from rapidly progressing disease with only lower motor neuron signs to very slowly progressing disease with both the upper and lower motor neuron systems affected. The patients showed different sites of onset, though the progressive bulbar palsy form of the disease appears to be rare among patients with a CuZn-superoxide dismutase mutation. The progression of motor signs and symptoms followed the same basic pattern in patients with different mutations. Extra-motor system symptoms were frequent among patients with a CuZn- superoxide dismutase mutation. The results suggest that patients with mutations in the CuZn-superoxide dismutase gene constitute one disease entity. The Val14Gly and Asp76Tyr mutations have not been reported before, and the latter is the first mutation to be found in exon 3 of the CuZn-superoxide dismutase gene.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
S. V. Seetharaman, M. Prudencio, C. Karch, S. P. Holloway, D. R. Borchelt, and P. J. Hart
Immature Copper-Zinc Superoxide Dismutase and Familial Amyotrophic Lateral Sclerosis
Experimental Biology and Medicine, October 1, 2009; 234(10): 1140 - 1154.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. M. Ravits and A. R. La Spada
ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration
Neurology, September 8, 2009; 73(10): 805 - 811.
[Abstract] [Full Text] [PDF]

Home page
 PNHome page
K Murray and R J Davenport
A rapidly progressive neuropathy
Practical Neurology, June 1, 2009; 9(3): 172 - 175.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
B. R. Stanton, D. Shinhmar, M. R. Turner, V. C. Williams, S. C. R. Williams, C. R. V. Blain, V. P. Giampietro, M. Catani, P. N. Leigh, P. M. Andersen, et al.
Diffusion Tensor Imaging in Sporadic and Familial (D90A SOD1) Forms of Amyotrophic Lateral Sclerosis
Arch Neurol, January 1, 2009; 66(1): 109 - 115.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Chio, B. J. Traynor, F. Lombardo, M. Fimognari, A. Calvo, P. Ghiglione, R. Mutani, and G. Restagno
Prevalence of SOD1 mutations in the Italian ALS population
Neurology, February 12, 2008; 70(7): 533 - 537.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
G Logroscino, B J Traynor, O Hardiman, A Chio', P Couratier, J D Mitchell, R J Swingler, E Beghi, and for EURALS
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 6 - 11.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. Beghi, A. Millul, A. Micheli, E. Vitelli, G. Logroscino, and for the SLALOM Group
Incidence of ALS in Lombardy, Italy
Neurology, January 9, 2007; 68(2): 141 - 145.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
L. Regal, L. Vanopdenbosch, P. Tilkin, L. Van Den Bosch, V. Thijs, R. Sciot, and W. Robberecht
The G93C Mutation in Superoxide Dismutase 1: Clinicopathologic Phenotype and Prognosis
Arch Neurol, February 1, 2006; 63(2): 262 - 267.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
P. A. Jonsson, K. S. Graffmo, P. M. Andersen, T. Brannstrom, M. Lindberg, M. Oliveberg, and S. L. Marklund
Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models
Brain, February 1, 2006; 129(2): 451 - 464.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. Sato, T. Nakanishi, Y. Yamamoto, P. M. Andersen, Y. Ogawa, K. Fukada, Z. Zhou, F. Aoike, F. Sugai, S. Nagano, et al.
Rapid disease progression correlates with instability of mutant SOD1 in familial ALS
Neurology, December 27, 2005; 65(12): 1954 - 1957.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P.W.J. Van Vught, N. A. Sutedja, J. H. Veldink, B. P.C. Koeleman, G. J. Groeneveld, C. Wijmenga, B. M.J. Uitdehaag, J. M.B.V. de Jong, F. Baas, J. H.J. Wokke, et al.
Lack of association between VEGF polymorphisms and ALS in a Dutch population
Neurology, November 22, 2005; 65(10): 1643 - 1645.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. R. Turner, A. Hammers, A. Al-Chalabi, C. E. Shaw, P. M. Andersen, D. J. Brooks, and P. N. Leigh
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS: studies with [11C]flumazenil PET
Brain, June 1, 2005; 128(6): 1323 - 1329.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. Al-Chalabi and P. N. Leigh
Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis?
Brain, March 1, 2005; 128(3): 451 - 453.
[Full Text] [PDF]

Home page
 BrainHome page
P. A. Jonsson, K. Ernhill, P. M. Andersen, D. Bergemalm, T. Brannstrom, O. Gredal, P. Nilsson, and S. L. Marklund
Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis
Brain, January 1, 2004; 127(1): 73 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. J. Lindberg, L. Tibell, and M. Oliveberg
Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: Decreased stability of the apo state
PNAS, December 24, 2002; 99(26): 16607 - 16612.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
T. M. Tikka, N. E. Vartiainen, G. Goldsteins, S. S. Oja, P. M. Andersen, S. L. Marklund, and J. Koistinaho
Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease
Brain, April 1, 2002; 125(4): 722 - 731.
[Abstract] [Full Text] [PDF]

Home page
 J HeredHome page
S. L. Green, R. J. Tolwani, S. Varma, P. Quignon, F. Galibert, and L. C. Cork
Structure, Chromosomal Location, and Analysis of the Canine Cu/Zn Superoxide Dismutase (SOD1) Gene
J. Hered., March 1, 2002; 93(2): 119 - 124.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
A Aggarwal and G Nicholson
Normal complement of motor units in asymptomatic familial (SOD1 mutation) amyotrophic lateral sclerosis carriers
J. Neurol. Neurosurg. Psychiatry, October 1, 2001; 71(4): 478 - 481.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. W. Orrell and D. A. Figlewicz
Clinical implications of the genetics of ALS and other motor neuron diseases
Neurology, July 10, 2001; 57(1): 9 - 17.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. Jacobsson, P. A. Jonsson, P. M. Andersen, L. Forsgren, and S. L. Marklund
Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations
Brain, July 1, 2001; 124(7): 1461 - 1466.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
L. P. Rowland and N. A. Shneider
Amyotrophic Lateral Sclerosis
N. Engl. J. Med., May 31, 2001; 344(22): 1688 - 1700.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
B. J. Traynor, M. B. Codd, B. Corr, C. Forde, E. Frost, and O. M. Hardiman
Clinical Features of Amyotrophic Lateral Sclerosis According to the El Escorial and Airlie House Diagnostic Criteria: A Population-Based Study
Arch Neurol, August 1, 2000; 57(8): 1171 - 1176.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. Weber, A. Eisen, H. G. Stewart, and P. M. Andersen
Preserved slow conducting corticomotoneuronal projections in amyotrophic lateral sclerosis with autosomal recessive D90A CuZn-superoxide dismutase mutation
Brain, July 1, 2000; 123(7): 1505 - 1515.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.